TABLE 3.
VEGFR antibody for active targeting of nanoparticle drug delivery systems.
| Types | Encapsulation percentage,EN% | Loading efficiency,LE% | Size (nm) |
|---|---|---|---|
| tLYP-1-PEG-NP Jin et al. (2018) | CK:83.4 | 14.8 | 188 |
| Parthenolide:70.7 | 2.9 | ||
| Flk-1-DSPE-PEG-NH2-NLC Liu et al. (2011) | CTX:98.43 + 0.51 | 3.34 ± 2.63 | 168.70 ± 2.07 |